Webinars
Endocrine and Rheumatologic Effects of Immune Checkpoint Inhibitors Recorded Webinar
Checkpoint inhibitors are being used for a growing number of oncologic indications. As we learn more about these agents, we learn more about their associated adverse events. Endocrine and rheumatologic adverse events are well documented, and clinicians need to be well-versed in their assessment, diagnosis, and management.